Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
Entry into a Material Definitive Agreement
17 Apr 24
8-K
Entry into a Material Definitive Agreement
6 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
20 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
19 Jul 23
8-K/A
Unregistered Sales of Equity Securities
10 Jul 23
8-K
Biostage Appoints Ron Packard to Board of Directors
10 Apr 23
8-K
Biostage Announces $6 Million Financing to Advance Clinical Trial
6 Apr 23
8-K
Unregistered Sales of Equity Securities
14 Mar 23
8-K
Biostage Announces Chairman and CEO Transition
7 Mar 23
8-K
Unregistered Sales of Equity Securities
26 Jan 23
Registration and prospectus
S-8
Registration of securities for employees
16 Nov 23
D
$6.01 mm in equity, sold $6.01 mm, 14 investors
14 Apr 23
RW
Registration withdrawal request
1 Feb 23
S-1/A
IPO registration (amended)
27 Oct 22
S-1
IPO registration
21 Jun 22
D
$5.06M in equity / options / securities to be acquired, sold $5.06M, 25 investors
8 Jun 22
D/A
$3M in equity / options / securities to be acquired, sold $2.6M, 2 investors
10 Sep 21
D
$2M in equity / options / securities to be acquired, sold $600K, 2 investors
23 Jun 21
D
$6.89M in equity, sold $500K, 1 investor
31 Aug 20
S-8
Registration of securities for employees
22 Jun 20
Proxies
DEFR14A
Revised proxy
7 Jun 23
DEFA14A
Additional proxy soliciting materials
7 Jun 23
DEF 14A
Definitive proxy
5 Jun 23
DEF 14A
Definitive proxy
6 Jul 22
PRE 14A
Preliminary proxy
22 Jun 22
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
Other
UPLOAD
Letter from SEC
7 Sep 17
CORRESP
Correspondence with SEC
15 Aug 17
UPLOAD
Letter from SEC
4 Aug 17
EFFECT
Notice of effectiveness
14 Apr 17
CORRESP
Correspondence with SEC
14 Apr 17
CORRESP
Correspondence with SEC
13 Apr 17
UPLOAD
Letter from SEC
12 Apr 17
EFFECT
Notice of effectiveness
9 Feb 17
CORRESP
Correspondence with SEC
7 Feb 17
CORRESP
Correspondence with SEC
7 Feb 17